NSW medical devices commercial training program open for early-career postgraduates
Expressions of interest are invited for a new training program that will arm early-career postgraduate researchers involved in medical technology and product-related research with the necessary entrepreneurial skills to successfully commercialise a medical technology.
Participants will complete a three-month course, delivered by ATP Innovations via professionals with deep domain expertise in the commercialisation of medical technologies. Expressions of interest will close on 21 July 2014.
The NSW Government established the Medical Devices Fund to help encourage and support investment in the development and commercialisation of medical devices and related technologies in NSW. As part of this objective, the Office for Health and Medical Research in partnership with ATP Innovations is for the first time offering this training program.
Following completion of the three-month NSW Medical Devices Commercialisation Training Program, up to two candidates will be selected based on merit and performance to participate in a two-year, paid, NSW-QB3 Rosenman Institute Scholar Program in the USA. The program is run by the University of California, San Francisco (UCSF) and the QB3 California Institute for Quantitative Biosciences.
This prestigious program will provide a hands-on opportunity to study and implement skills in medical device development and commercialisation. Candidates will work with clinicians and medical device innovators to develop a technology from concept to commercialisation.
The application guidelines and FAQs are available at http://atp-innovations.com.au/.
AI enables precise gene editing
A newly developed tool utilises AI to predict how cells repair their DNA after it is cut by gene...
Shingles vaccine may reduce risk of heart attack and stroke
Vaccination with either the recombinant herpes zoster vaccine or the live-attenuated zoster...
Perioperative trial offers insights into brain cancer treatment
Victorian brain cancer researchers have used an innovative process to learn how a new drug...